Ligand Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Ligand Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ligand Pharmaceuticals Inc Strategy Report
- Understand Ligand Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Ligand Pharmaceuticals Catalyst Calendar
Proactively evaluate Ligand Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Ligand Pharmaceuticals Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 03 Aug 2020 | Phase I Trial Completion | Ligand Pharmaceuticals Inc; Medpace Holdings Inc; Nucorion Pharmaceuticals Inc | LGND; MEDP | NUC-1010 | Infectious Disease | Hepatitis B | Clinical Trial Registry |
| 01 Aug 2020 | Phase II/III Trial Completion | Ligand Pharmaceuticals Inc; Palvella Therapeutics LLC | LGND | sirolimus | Genetic Disorders | Pachyonychia Congenita (Pachyonychia) | Company Press Release |
| 01 Aug 2020 | Phase I Trial Results | Ligand Pharmaceuticals Inc; Medpace Holdings Inc; Nucorion Pharmaceuticals Inc | LGND; MEDP | NUC-1010 | Infectious Disease | Hepatitis B | Company Press Release |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer